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Background.– Urinary disorders are frequent in multiple sclerosis and can lead
to urological complications and decreased quality of life. Urinary management
guidelines are scarce and targeted to neuro-urology specialists.
Objective.– We present a validated algorithm dedicated to neurologists, PMR and
general practitioners to facilitate first-line evaluation and treatment of urinary
disorders associated with multiple sclerosis: the FLUE-MS algorithm (First-Line
Urological Evaluation in Multiple Sclerosis).
Methods.– This algorithm was derived from literature analysis, evaluated by
an expert panel and validated by means a Delphi method. Urinary Bothersome
Questionnaire in Multiple Sclerosis is also presented. This algorithm is compared
with the other available guidelines.
Discussion.– The FLUE-MS algorithm is designed for neurologists, PMR and
general practitioners, enabling identification of ‘red flags’, timely patient referral
to specialist neuro-urology units, and appropriate first-line therapy.
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Background.– Therapeutic management of urinary disorders in MS is a challenge
for the teams in charge because symptoms, pathophysiology, complications and
therapeutic options may vary with time and deficiencies associated with the
evolution of the disease. Early diagnostic tools, prevention of complications,
symptomatic improvement are the goals of treatment.
Objective.– We review the different medical and surgical options that are val-
idated for the treatment of Urinary disorders in MS. Recent advances such
as botulinum toxin detrusor injections, sacral or tibial neuromodulation are
presented.
Methods.– This lecture derived from an extensive review of the literature.
Discussion.– Therapeutic management of urinary disorders is important in term
of quality of life improvement. Access to medical treatment is actually limited
despite numerous innovative treatments at each stage of the disease. Early diag-
nostic, appropriate follow-up and multidisciplinary approach guaranty the best
management.
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Background.– Sexual dysfunction (SD) is highly prevalent in patients with mul-
tiple sclerosis (MS), affecting 50% to 80% of both male and female patients,
and has a major impact on quality of life. Men present with erectile and ejac-
ulatory dysfunctions (retarded, premature or anejaculation), and partial loss of
libido. This leads to decreased frequency of intercourse, difficulty with achieving
orgasm, and dissatisfaction with sexual performance.
Results.– Women commonly report reduced genital sensation, reduced vagi-
nal lubrication, difficulty with arousal, and difficulty reaching orgasm. In both
sexes, fatigue, spasticity, hand tremors, neuropathic pain, and anxiety about
incontinence contribute to SD. Psychosocial and cultural issues also need eval-
uating, and include depression, performance anxiety, changes in family roles,
lowered self-esteem, loss of confidence. In men, treatments are similar to that of
other neurological diseases: erectile dysfunction can be treated with phosphodie-
sterase inhibitors and intracavernosus injections, though with limited efficacy.
Ejaculatory dysfunction is managed through penile vibratory stimulation and
midodrine. In women, vaginal dryness can be treated with adequate amount of
water-based lubricants. Sex therapy has a prominent role.
Discussion.– A comprehensive assessment of all theses aspects must be taken
into account. The treatment of SD requires multidisciplinary teamwork and
cooperation among specialists, individual patients and partners.
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Objective.– Urinary symptoms are very frequent in MS [1]. The high prevalence
of women in MS and the age demographic affected in MS suggests that SUI could
be common.
Methods.– Three hundred and forty-three MS women with urinary symptoms
questionnaire (USP), quality of life questionnaire (Qualiveen), Expanded Dis-
ability Status Scale (EDSS), and urodynamic exploration were selected.
Results.– The mean age was 48.8 years old (20–77); mean EDSS was 5.45.
The mean number of vaginal deliveries was 1.4. Hundred and fifty-six women
(45.5%) reported SUI (USP SUI > 2/9). Three hundred and twelve women (91%)
had overactive bladder (OAB) (USP OAB > 2/21). Ninety-seven percent of
women had an associated SUI and OAB. The average uretral closure pressure
measurement (MUCP) was 69 cmH20. Women with SUI had significantly lower
MUCP and higher age (P < 0.05). No correlation was found between SUI and
detrusor overactivity (DO) in urodynamics (P > 0.05), the number of vaginal
deliveries (P > 0.05) or EDSS score (P > 0.05).
Discussion.– The prevalence of SUI in MS women is 45.5%, independent of the
degree of disability. SUI is correlated with the age and the MUCP. Our results
do not support the SUI prevalence data described [2].
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Multiple sclerosis (MS) is a chronic immune mediated disease affecting the cen-
tral nervous system, and characterized by demyelination and axonal damage.
The estimated prevalence of MS is approximately 2.5 million cases worldwide
and the disease is the first most common cause of neurological disability in
young adults. If untreated, MS typically leads to substantial accumulation of
both physical and cognitive disability over time. For that reason, early use of
disease-modifying therapies is required. These treatments should reduce relapse
rate, limit the onset of new demyelinating lesions and postpone the develop-
ment of long-term disability. Currently first-line-approved immunomodulator
therapies for MS reduce disease activity and the accumulation of disability in
relapsing remitting MS. Although these first-line treatments have shown excel-
lent safety profiles, their effects are modest and all have to be given by injection.
Immunosuppressive drugs are also approved for treatment of MS as second-
line therapy, demonstrating greater efficacy but also many severe safety adverse
events. Thus, there remains an unmet need for the development of more effective
and well-tolerated oral therapies for the treatment of MS. Based on results of
large randomized controlled trials, a number of oral medications have already
been or will be approved.
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Objective.– This study aimed to test the hypothesis that clinical improvement
following physical rehabilitation is associated with regional brain plasticity in
disabled patients suffering from multiple sclerosis (MS).
Results.– Fourteen MS patients with a lower limb motor deficit underwent a
one-month standardized physical rehabilitation protocol. Clinical examination,
resting-state functional MRI (rs-fMRI) and structural MRI were performed at
inclusion, just after rehabilitation, and three months after the end of rehabilita-
tion. Topology of brain networks was analysed based on graph-theory method
applied to rs-fMRI data. Morphological variations in grey matter (GM) were
determined using longitudinal Voxel-Based Morphometry method applied to
3D T1-weighted images.
Discussion.– Graph-theory analysis evidenced after rehabilitation an increase
of the local connectivity in the default mode network (DMN) and the central
executive network (CEN). The amount of connectivity changes depicted in the
DMN and the CEN was correlated to the clinical improvement. Structural MRI
evidenced a significant increase in GM density in the left fronto-orbital cortex
immediately after rehabilitation correlating with clinical improvement. After the
end of rehabilitation, structural and functional brain reorganization progressively
disappeared and clinical performances returned to baseline level.
Conclusion.– The study evidences that the transient clinical improvement fol-
lowing physical rehabilitation in MS patients is associated with reversible
plasticity mechanisms.
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During a long time physical activity was not recommended for patients with
multiple sclerosis for fear of worsening neurological symptoms. The practice
of physical activity depends on the possibilities of adaptation to stress, and
disability. For high EDSS scores cardiovascular abnormalities adaptation and
impaired respiratory function may be observed with perturbations of exercise
testing as consequences. Muscle deficits, coordination disorders can also be an
obstacle to physical activity increasing the deconditioning consecutive to the
restriction of physical activity.
Various studies have shown the benefit of physical training with an improvement
in VO2 max, gait parameters and fatigue. A real impact on quality of life is also
observed. Regular physical activity is necessary for maintaining the benefit of
rehabilitation training programs.
The combination of muscle strengthening potentiates the benefit obtained. Sports
should be recommended depending on the clinical feature and adapted to the
fatigue in his practice and this al all along the disease course.
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Multiple sclerosis is an inflammatory disease of central nervous system with
both scattered and evolutive lesions. It is characterized by the appearance at a
time variable in the development of disorders of balance and gait moving towards
progressive disability.
In MS, balance impairment is responsible for falls that occur at different
stages of the disease. Imbalance and falls are related not only to impairment of
motor control but also of the proprioception, the cerebellar function and vision.
Spasticity and cognitive troubles have also been related to increased risk of falls.
